Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-160,588
Closed -$15.1M 50
2022
Q2
$15.1M Sell
160,588
-306,297
-66% -$33M 0.63% 33
2022
Q1
$57.9M Buy
466,885
+21,267
+5% +$2.88M 2.05% 20
2021
Q4
$69.7M Sell
445,618
-30,939
-6% -$4.92M 2.5% 18
2021
Q3
$79.7M Sell
476,557
-40,187
-8% -$7.47M 2.72% 17
2021
Q2
$101M Sell
516,744
-3,694
-0.7% -$681K 3.65% 14
2021
Q1
$95.1M Buy
520,438
+32,163
+7% +$5.65M 3.85% 13
2020
Q4
$81.2M Sell
488,275
-113,993
-19% -$16.8M 3.53% 12
2020
Q3
$77.7M Buy
602,268
+130,542
+28% +$16.2M 3.56% 9
2020
Q2
$52.1M Sell
471,726
-75,637
-14% -$7.5M 2.36% 21
2020
Q1
$44.1M Buy
547,363
+130,488
+31% +$13.1M 2.31% 20
2019
Q4
$48.5M Buy
+416,875
New +$40.3M 2.18% 21

Other funds holding QRVO

Antipodes Partners's QRVO Position: Q3 2022 in Review

Antipodes Partners sold out of Qorvo (QRVO) in Q3 2022, closing a stake of 160,588 shares — an estimated $15.1M sold.

Antipodes Partners first reported a position in QRVO in Q4 2019 and held it in 11 quarters. The position peaked at $101M in Q2 2021. 541 funds tracked by Wall St. Rank hold QRVO as of Q3 2022.

  • Antipodes Partners reported no remaining Qorvo position as of Q3 2022 after selling out during the quarter.
  • Antipodes Partners sold 160,588 Qorvo shares in Q3 2022, an estimated $15.1M.
  • Antipodes Partners first reported a position in Qorvo in Q4 2019 and held it in 11 quarters.
  • Antipodes Partners's Qorvo position peaked at $101M in Q2 2021.
  • 541 funds tracked by Wall St. Rank held Qorvo as of Q3 2022.

Based on Antipodes Partners's 13F filing for Q3 2022, filed 10 Nov 2022.